Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04896476 · ClinicalTrials.gov registry record · NA
Prospective Feasibility Study Evaluating EchoMark LP Placement and EchoSure Measurements for Subjects Requiring Arteriovenous Fistulae
A NA study of Kidney Diseases and Arteriovenous Fistula, sponsored by Sonavex.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 4
- Study locations
NCT04896476 is a NA study of Kidney Diseases and Arteriovenous Fistula that is active but no longer recruiting, run by Sonavex. The registered enrollment target is 20 participants, below the 1,785-participant average among 38 other Kidney Diseases trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT04896476, a NA study of Kidney Diseases and Arteriovenous Fistula, is active but no longer recruiting, sponsored by Sonavex.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 4
- Study locations
Study Summary
Multi-center trial to assess the feasibility and safety of the EchoMark LP and the EchoMark diagnostic ultrasound system for assessing AV fistula blood flow, diameter, and depth.
Conditions Studied
Interventions
- DEVICE EchoMark / EchoSure
Study Locations (4)
Alabama
- Trinity Research Group - Dothan
Arizona
- SKI Vascular Center - Peoria
Michigan
- Michgan Vascular Center - Flint
North Carolina
- Surgical Specialist of Charlotte - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-01-21 |
| Est. Completion | 2025-06-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04896476
The ClinicalTrials.gov registry entry for NCT04896476 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,785-participant average among 38 other Kidney Diseases trials with a reported enrollment target (99% lower). The listed sponsor is Sonavex, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Kidney Diseases appearing as the primary indexed condition, and to 1 intervention - of which EchoMark / EchoSure is the first listed.
NCT04896476 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Alabama, Arizona, Michigan.
Frequently Asked Questions
What is clinical trial NCT04896476 about?
NCT04896476 is a clinical study titled "Prospective Feasibility Study Evaluating EchoMark LP Placement and EchoSure Measurements for Subjects Requiring Arteriovenous Fistulae". Multi-center trial to assess the feasibility and safety of the EchoMark LP and the EchoMark diagnostic ultrasound system for assessing AV fistula blood flow, diameter, and depth.
What is the current status of trial NCT04896476?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2022-01-21. Estimated completion is 2025-06-06.
What conditions does trial NCT04896476 study?
This clinical trial studies the following conditions: Kidney Diseases, Arteriovenous Fistula.
What interventions are being tested in trial NCT04896476?
The interventions under investigation include: EchoMark / EchoSure (DEVICE).
Who is sponsoring clinical trial NCT04896476?
This trial is sponsored by Sonavex, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04896476 being conducted?
This trial has 4 study locations across Alabama, Arizona, Michigan, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease
RECRUITING · NA
-
Supporting VETerans With Kidney Disease Through Food As Medicine
RECRUITING · NA
-
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
RECRUITING · NA
-
Dietary Intervention to Improve Kidney Transplant Outcomes
RECRUITING · NA
-
Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
RECRUITING · NA
-
Expanding Live Donor Kidney Transplantation Through Advocacy Training and Social Media
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.